Thyroseq genomic classifier tests
Ended Awarded Last action
- Contract number
- 36C24625N0029
- Awardee
-
Cytopath Biopsy Lab Inc. UEI KC5VWAGMNLT6
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $80,000
Award facts
- Contract value 100% obligated
- $80,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- 6630 Chemical Analysis Instruments
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Port Chester, NY 10573, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$4,000 | |
| Supplemental Agreement for work within scope | $24,000 | |
| Original award | $60,000 |
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 6 (VISN 6), awarded a $80,000 firm fixed-price blanket purchase agreement (BPA) call to Cytopath Biopsy Lab Inc. (doing business as Cblpath) on October 1, 2024, for ThyroSeq Genomic Classifier Tests. The contract is scheduled for completion by September 30, 2025, and represents a call order against an existing BPA vehicle. Services will be performed in Port Chester, New York. This award was made without a small business set-aside designation, reflecting Cblpath's positioning as a competitive prime contractor. The contract purpose includes de-obligating remaining funds to closeout the associated contract vehicle.
Cblpath specializes in molecular diagnostic laboratory services with a focus on thyroid cancer screening and diagnosis through its proprietary ThyroSeq technology, which analyzes genetic mutations in thyroid nodules to support clinical decision-making. The company maintains a substantial federal contracting presence with the Department of Veterans Affairs across multiple regional networks, with a contract portfolio exceeding 50 awards valued between $2,000 and $2.31 million since 2021. VISN 6 has multiple active indefinite delivery contracts and BPAs with Cblpath, including a $2.25 million BPA awarded in October 2025, through which the agency procures ThyroSeq genomic testing services to support veterans' healthcare and thyroid cancer screening programs on a per-test basis using firm fixed-price structures.
Quick answers
Who was awarded contract 36C24625N0029?
36C24625N0029 was awarded to Cytopath Biopsy Lab Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C24625N0029 worth?
The government has obligated $80,000 on 36C24625N0029.
Is contract 36C24625N0029 an order under another contract?
Yes. 36C24625N0029 is a BPA call under 36C24624A0017, a blanket purchase agreement.
Was contract 36C24625N0029 competed?
The extent of competition for 36C24625N0029 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award